Published in Hepatitis Weekly, November 15th, 1999
Because access to sterile syringes is limited, transmission of blood-borne infections to injection drug users, their partners, and their children continues to be an enormous public health concern.
In a joint letter, the American Medical Association (AMA), the American Pharmaceutical Association (APhA), the Association of State and Territorial Health Officials (ASTHO), the National Association of Boards of Pharmacy (NABP), and the National Alliance of State and Territorial AIDS Directors (NASTAD) urged...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (1999-11-15)
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.